Internal Medicine, Hematology & Oncology · Chattanooga, TN
NPI
1619107414
Since 2009
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1032 McCallie Ave Ste 200
Chattanooga, TN, 37403
Phone (423) 752-5004
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.3M
159,491 services
Medicare patients, 2024
596
Average age 74
Drug cost, 2024
$4.9M
1,641 prescriptions
Company payments, 2025
$1,480
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sumana Nagireddy was code J9271 (injection, pembrolizumab, 1 mg), 16,000 times for 14 patients. In total Sumana Nagireddy billed 159,491 services in 177 codes, and Medicare paid $2.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 16,000 | 14 | $44.79 | $717K |
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 15,750 | 13 | $0.86 | $13K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 9,600 | 21 | $0.11 | $1,064 |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 8,540 | 11 | $2.26 | $19K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 3,300 | 28 | $15.97 | $53K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,652 | 36 | $0.09 | $149 |
| 85025 Blood Count | Office | 1,458 | 390 | $7.50 | $11K |
| 36415 Venipuncture Blood Collection | Office | 1,155 | 362 | $8.51 | $9,824 |
| 80053 Clinical Chemistry | Office | 1,094 | 321 | $10.25 | $11K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 770 | 24 | $0.73 | $562 |
| J9190 Injection, fluorouracil, 500 mg | Office | 659 | 11 | $2.34 | $1,544 |
| 99215 Office E&M - Established | Office | 440 | 107 | $126.06 | $55K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 328 | 212 | $12.02 | $3,943 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 320 | 12 | $0.25 | $80.89 |
| 99214 Office E&M - Established | Office | 304 | 188 | $84.08 | $26K |
By year: 2022 $1.5M for 109,875 services; 2023 $1.9M for 136,954 services; 2024 $2.3M for 159,491 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,458 | 390 | $7.50 | $11K |
| 36415 Venipuncture Blood Collection | 1,155 | 362 | $8.51 | $9,824 |
| 80053 Clinical Chemistry | 1,094 | 321 | $10.25 | $11K |
| 82784 Immunoassay | 303 | 44 | $9.11 | $2,761 |
| 83540 Clinical Chemistry | 254 | 155 | $6.28 | $1,596 |
| 82728 Clinical Chemistry | 254 | 156 | $13.24 | $3,364 |
| 83550 Clinical Chemistry | 254 | 155 | $8.53 | $2,166 |
| 83521 Immunoassay | 216 | 53 | $16.93 | $3,656 |
| 82607 Clinical Chemistry | 147 | 127 | $14.78 | $2,173 |
| 84443 Clinical Chemistry | 146 | 63 | $16.46 | $2,403 |
Medicare prescription drug claims, 2024
In 2024, the drug Sumana Nagireddy prescribed most often to Medicare patients was Anastrozole, with 132 prescriptions and refills. In total Sumana Nagireddy wrote 1,641 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 132 | 352 | 52 | $2,887 |
| Ondansetron Odt Ondansetron | 110 | 110 | 64 | $1,984 |
| Letrozole Generic | 86 | 232 | 34 | $2,169 |
| Prochlorperazine Maleate Generic | 81 | 81 | 50 | $1,320 |
| Eliquis Apixaban | 63 | 95 | 17 | $53K |
| Prednisone Generic | 56 | 58 | Under 11 | $202 |
| Xarelto Rivaroxaban | 44 | 54 | Under 11 | $30K |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 43 | 43 | 25 | $501 |
| Potassium Chloride Generic | 41 | 55 | 20 | $541 |
| Dexamethasone Generic | 39 | 39 | 21 | $950 |
| Abiraterone Acetate Generic | 38 | 39 | Under 11 | $82K |
| Ibrance Palbociclib | 37 | 37 | Under 11 | $588K |
| Warfarin Sodium Generic | 32 | 63 | Under 11 | $231 |
| Calquence Acalabrutinib Maleate | 30 | 30 | Under 11 | $335K |
| Mirtazapine Generic | 30 | 58 | 16 | $287 |
Brand drugs: - claims; generic drugs: 1,171 claims; opioid claims: 70.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sumana Nagireddy $1,480 ($1,480 in general payments such as food, travel and fees) from 29 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $339.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 5 | $339 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $152 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $94.25 |
| Gilead Sciences, Inc. GILD | 3 | $70.87 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $62.87 |
| Janssen Biotech, Inc. JNJ | 2 | $60.12 |
| Pharmacosmos Therapeutics Inc. | 3 | $60.07 |
| Incyte Corporation INCY | 2 | $51.69 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $49.81 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $45.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.